ELITechGroup Biomedical Systems, World Leader for Laboratory Diagnosis of Cystic Fibrosis, Launches
LOGAN, Utah--(BUSINESS WIRE)--Aug 16, 2018--ELITechGroup Biomedical Systems (EBS), known for worldwide transformation and innovation of...
IRT Test
Cystic fibrosis is caused by mutations in the CFTR gene, which results in thick mucus building up around organs and tissues. This is...
Orkambi Not Seen to Significantly Improve Blood Glucose Levels in CF Patients in Small Study
Analysis of blood glucose levels in cystic fibrosis (CF) patients being treated with Orkambi (ivacaftor/lumacaftor) shows that the...
Cystic Fibrosis Further Explained by Rare Cell Type Discovery
Investigators from the Broad Institute of MIT and Harvard and Massachusetts General Hospital (MGH) have discovered a rare cell type in...
New Gene Therapy Could Treat Cystic Fibrosis With One Dose
A new partnership in the UK will develop a gene therapy for cystic fibrosis that could treat the disease with a single dose. Cystic...
Cystic Fibrosis Treatment Approved for Use in Children Aged 2 to 5 Years
Officials with the FDA have updated the label of lumacaftor/ivacaftor (Orkambi, Vertex Pharmaceuticals), approving the treatment's use in...